drugset / Trial / NCT00005876

Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery

NCT00005876

Phase 2 Unknown Astex Pharmaceuticals, Inc.
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of nitrocamptothecin in treating patients who have locally advanced or metastatic stomach cancer that cannot be removed during surgery.

Timeline

Start
2000-04
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject rubitecan Unknown Oral